Le Li is a Professor at the First Affiliated Hospital of Harbin Medical University. He received his Ph.D. degree in General Surgery from the Harbin Medical University, Harbin, China. He is now committing himself to exploring pancreatic cancer chemotherapy resistance mechanisms. At the same time, he has received support from many national funds, such as the Natural Science Foundation of China. He has published 59 papers with 955 citations and has an h-index of 17 (Scopus, 7 December 2023). His research topics mainly include: chronic pancreatitis, pancreatic cancer, acute pancreatitis, immunotherapy, gut microbiome, CD8+ T cells, and autophagy.